Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,918
Active & Responsive
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
for
Chronic Cough (CC), Refractory Chronic Cough,
Location: Atlanta GA, Missoula MT
Sponsor: University of Montana
Sex: All
Age: 18 - 70+
Code: NCT06960759
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: New York NY, Philadelphia PA, Atlanta GA, Dallas TX,
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07517133
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for
Transfusion-dependent Alpha-Thalassemia,
Location: New York NY, Philadelphia PA, Atlanta GA, Dallas TX
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07506863
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 6 - 11
Code: NCT07717879
Phase 3, Recruiting
Active & Responsive
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
for
Coronary Artery Disease Risk Factors Multiple,
Location: Boston MA, New York NY, Charlottesville VA, Durham NC,
Sponsor: Duke University
Sex: All
Age: 30 - 60
Code: NCT07232069
Phase 3, Recruiting
Active & Responsive
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
for
Stomatitis
Location: Wynnewood PA, East Syracuse NY, Wilson NC, Athens GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07357597
Recruiting
Active & Responsive
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Locally Advanced Non-Small Cell Lung Cancer (NSCLC),
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Boston MA, Atlanta GA, Peoria IL, Orange CA, Irvine CA,
Sponsor: CatalYm GmbH
Sex: All
Age: 18 - 70+
Code: NCT07219459
Phase 2, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Winston-Salem NC,